×
0 0 0 0.037037037037037 0.0148148148148149 0 -0.0266666666666666 -0.0237037037037037
Stockreport

UPDATE 1-Generic drugmaker Endo's profit beats estimates [Reuters]

ENDO INTL PLC ORDINAR (ENDP)  More Company Research Source: Reuters
Last endo intl plc ordinar earnings: 5/8 06:30 am Check Earnings Report
US:NASDAQ Investor Relations: investor.endo.com/newsroom/news-releases
PDF UPDATE 1-Generic drugmaker Endo's profit beats estimates (Adds details on segment business) Feb 27 (Reuters) - Generic drugmaker Endo International Plc reported higher-than-expected quarterly profit, helped by higher sales of its sterile injectables and flagship drug Xiaflex. Sales in the sterile injectables business rose 16 percent to $167.3 million, while its specialty drugs business, which includes Xiaflex, raked in $124 million, up 8 percent from a year earlier. Xiaflex is approved to treat Peyronie’s disease, a condition that causes painful erections, and Dupuytren’s contracture, a disease that impairs a person’s ability to use their fingers. Net loss attributable to shareholders narrowed to $368.4 million, or $1.65 per share, in the fourth quarter ended Dec. 31 from $3.34 billion, or $14.98 per share, a year earlier. Excluding items, Endo earned 77 cents per share, above the average analysts’ estimate of 61 cents per share, according to Thomson Reuters I/B/E/S. The company booke [Read more]

IMPACT SNAPSHOT EVENT TIME: ENDP
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS